150 related articles for article (PubMed ID: 23163617)
1. Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis.
Thornton SL; Lo J; Clark RF; Wu AH; Gerona RR
Clin Toxicol (Phila); 2012 Dec; 50(10):1165-8. PubMed ID: 23163617
[TBL] [Abstract][Full Text] [Related]
2. [A case of acute psychotic episode after a single dose of ecstasy].
Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
[TBL] [Abstract][Full Text] [Related]
3. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
Every-Palmer S
Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
[TBL] [Abstract][Full Text] [Related]
4. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings.
Hermanns-Clausen M; Kneisel S; Szabo B; Auwärter V
Addiction; 2013 Mar; 108(3):534-44. PubMed ID: 22971158
[TBL] [Abstract][Full Text] [Related]
5. Three cases of "spice" exposure.
Simmons J; Cookman L; Kang C; Skinner C
Clin Toxicol (Phila); 2011 Jun; 49(5):431-3. PubMed ID: 21740143
[TBL] [Abstract][Full Text] [Related]
6. The designer drug situation in Ibiza.
Lora-Tamayo C; Tena T; Rodríguez A; Moreno D; Sancho JR; Enseñat P; Muela F
Forensic Sci Int; 2004 Mar; 140(2-3):195-206. PubMed ID: 15036441
[TBL] [Abstract][Full Text] [Related]
7. [Bromo-Dragonfly poisoning of 18-year-old male].
Nielsen VT; Høgberg LC; Behrens JK
Ugeskr Laeger; 2010 May; 172(19):1461-2. PubMed ID: 20470659
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism.
Hutter M; Moosmann B; Kneisel S; Auwärter V
J Mass Spectrom; 2013 Jul; 48(7):885-94. PubMed ID: 23832945
[TBL] [Abstract][Full Text] [Related]
9. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
Liechti M
Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
[TBL] [Abstract][Full Text] [Related]
10. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction.
Kneisel S; Auwärter V
J Mass Spectrom; 2012 Jul; 47(7):825-35. PubMed ID: 22791249
[TBL] [Abstract][Full Text] [Related]
11. Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP).
Wood DM; Dargan PI
Clin Toxicol (Phila); 2012 Sep; 50(8):727-32. PubMed ID: 22882169
[TBL] [Abstract][Full Text] [Related]
12. Spicing things up: synthetic cannabinoids.
Spaderna M; Addy PH; D'Souza DC
Psychopharmacology (Berl); 2013 Aug; 228(4):525-40. PubMed ID: 23836028
[TBL] [Abstract][Full Text] [Related]
13. Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong.
Tung CK; Chiang TP; Lam M
East Asian Arch Psychiatry; 2012 Mar; 22(1):31-3. PubMed ID: 22447803
[TBL] [Abstract][Full Text] [Related]
14. ["Spice"--synthetic cannabinoids with dangerous effects].
Personne M; Westerbergh J; Hammer-Pettersen L
Lakartidningen; 2014 Nov; 111(47):2105-7. PubMed ID: 25386644
[TBL] [Abstract][Full Text] [Related]
15. Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl)benzofuran (6-APB) and cannabis.
Chan WL; Wood DM; Hudson S; Dargan PI
J Med Toxicol; 2013 Sep; 9(3):278-81. PubMed ID: 23733714
[TBL] [Abstract][Full Text] [Related]
16. Rave drugs: pharmacological considerations.
Klein M; Kramer F
AANA J; 2004 Feb; 72(1):61-7. PubMed ID: 15098519
[TBL] [Abstract][Full Text] [Related]
17. [Emergencies associated with the consumption of designer drugs, hallucinogens and amphetamines treated at 15 Spanish hospitals in 1994. Work Group on the Study of Emergencies due to Psychostimulants].
Rodríguez Arenas MA; Barrio Anta G; de la Fuente de Hoz L; Royuela L
Rev Clin Esp; 1997 Dec; 197(12):804-9. PubMed ID: 9477670
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids and psychosis.
D'Souza DC
Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS.
Maresová V; Chadt J; Prikryl L
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795
[TBL] [Abstract][Full Text] [Related]
20. Synthetic cannabinoid intoxication: a case series and review.
Harris CR; Brown A
J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
